By David | Biotech News Today | Updated October 17, 2026
People searching for a biotech startup companies list usually want one of three things: names of promising young companies, a way to find startups to follow or work for, or a sense of what these companies actually do. This guide gives you a starting list of recently funded biotech startups, explains how to read it, and shows you how to build your own list from reliable sources.
If you are new to the field, start with our guide on what biotech startups are and how they work.
How to Read This List
This is not a ranking and it is not investment advice. The companies below were chosen because they were named in recent funding reports in 2026. A large funding round shows that investors are interested, but it does not prove that a company’s science will work. Many young biotech companies fail in clinical trials, so always look at the evidence behind a company before drawing conclusions.
Recently Funded Biotech Startups
| Company | What Was Reported | Area |
|---|---|---|
| Isomorphic Labs | A $2.1 billion funding round reported in the first half of 2026 | AI drug discovery |
| Chai Discovery | A $400 million Series C announced in July 2026 | AI drug discovery |
| Osanni Bio | $190 million reported in June 2026 | Early-stage biotech |
| cAMPfield | A $180 million Series A in June 2026 | Oral treatment for inflammatory bowel disease |
| SonoThera | A $125 million Series B in June 2026, backed by large pharmaceutical investors | Genetic medicine delivery |
| Kailera Therapeutics | Launched with a $400 million Series A in 2024; priced a $625 million IPO in April 2026 | Obesity and metabolic disease |
These details come from BioPharma Dive, Fierce Biotech, Labiotech, and Value Add VC, linked at the end of the article. Company descriptions are short summaries; visit each company’s own website for its latest pipeline and news.
What These Companies Have in Common
Several patterns stand out:
- AI drug discovery draws very large checks. Isomorphic Labs and Chai Discovery both raised big rounds, showing strong investor interest in using artificial intelligence to design medicines.
- Late-stage rounds dominate. Large Series B, Series C, and IPO rounds are more common than small seed rounds right now.
- Disease focus matters. Cancer, immune, and metabolic diseases attract much of the funding. You can see the wider picture in our report on biotech startup funding in 2026.
A Warning About Early-Stage Startups
A BioCentury analysis found that seed and Series A financing lagged behind the wider biotech recovery in the first half of 2026. The number of disclosed early rounds fell to the lowest first-half tally in a decade, and the money raised in those rounds was down 15 percent from a year earlier, at $4.4 billion. This means newer startups still face a tougher road than the headline numbers suggest.
Types of Biotech Startups to Look For
A good list should cover different kinds of companies, not only drug developers.
| Type | What to Look For |
|---|---|
| Therapeutics | A clear disease target and data from lab or clinical studies |
| AI and computational biology | Real biological validation, not only software |
| Gene and cell therapy | Safe and scalable delivery and manufacturing plans |
| Diagnostics | Accuracy data and a path to regulatory approval |
| Tools and platforms | Customers or partners who use the technology |
To learn how these companies make their products at scale, read our explainer on what a CDMO is.
How to Build Your Own Biotech Startup List
Lists go out of date quickly, so it helps to know how to find fresh names yourself.
- Follow funding trackers. Fierce Biotech, Labiotech, and BioPharma Dive publish regular roundups of funding rounds.
- Check regional hubs. Our guides to Bay Area biotech startups and biotech startups in New York name incubators and clusters worth exploring.
- Use official databases. The U.S. National Institutes of Health and the FDA publish grant and trial information that can reveal early-stage work. Clinical trial listings are on ClinicalTrials.gov.
- Read each company’s website and news page. Look at its pipeline, leadership, investors, and partners.
- Track changes over time. Note which companies hit milestones, raise new money, or are acquired.
What to Check Before Following or Applying to a Startup
- Who founded it, and what is their scientific track record?
- How advanced is the lead product?
- Who are the investors and partners?
- How much cash does the company have?
- Does it have more than one program, so a single failure is not fatal?
Frequently Asked Questions
What is a biotech startup? It is an early-stage company that uses biological science to develop medicines, tests, or other products.
Which biotech startups have raised the most money in 2026? Reports name AI drug discovery companies such as Isomorphic Labs and Chai Discovery among the largest rounds, but rankings depend on the data source.
Is a big funding round a sign a startup will succeed? Not necessarily. It shows investor confidence, but clinical trials can still fail.
Where can I find an up-to-date list of biotech startups? Funding trackers from Fierce Biotech and Labiotech, along with BioPharma Dive reports, are good places to start.
Are there biotech startups for students to work at? Yes. Many startups offer internships and entry-level roles, especially in hubs like Boston, the Bay Area, and New York.
Final Thoughts
A biotech startup companies list is a useful starting point, but the real value comes from knowing how to evaluate each company and keep your list current. Bookmark this page and the funding trackers above, and check Biotech News Today for regular updates.
Sources
- BioPharma Dive, biotech venture capital funding in the first half of 2026: https://biopharmadive.com/news/biotech-venture-capital-funding-2026-first-half/824881
- Fierce Biotech, venture capital coverage and fundraising tracker (June 2026): https://www.fiercebiotech.com/keyword/biotech-venture-capital
- Labiotech, biotech funding rounds in April 2026: https://www.labiotech.eu/?p=136796
- Value Add VC, Q3 2026 health and biotech funding rounds: https://valueaddvc.com/blog/q3-2026-health-and-biotech-funding-rounds-ranked
- BioCentury, Seed and series A financing lagged biotech’s broader recovery in 1H26 (July 18, 2026): https://www.biocentury.com/article/660172/seed-and-series-a-financing-lagged-biotech-s-broader-recovery-in-1h26
- Pharmaceutical Technology, biotech venture financing report (October 2025): https://www.pharmaceutical-technology.com/newsletters/biotechs-brush-off-sector-headwinds-in-venture-financing-rebound
Leave a Reply